Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Salih Emri"'
Autor:
Ulrich Gatzemeier, Michael Boyer, Paolo Paoletti, Salih Emri, Christian Manegold, Claude Denham, Nicholas J. Vogelzang, James J. Rusthoven, James T. Symanowski, Clet Niyikiza, E. Kaukel, Pierre Ruffié
Publikováno v:
Journal of Clinical Oncology. 41:2125-2133
PURPOSE Patients with malignant pleural mesothelioma, a rapidly progressing malignancy with a median survival time of 6 to 9 months, have previously responded poorly to chemotherapy. We conducted a phase III trial to determine whether treatment with
Publikováno v:
Asian Cardiovascular and Thoracic Annals. 24:98-100
Rhabdomyosarcoma is an aggressive malignant tumor of childhood, originating from immature cells that are destinated to form striated skeletal muscle. It usually arises in the head and neck or the extremities. Primary diffuse pleural rhabdomyosarcoma
Publikováno v:
British Journal of Cancer
This review summarises the results of previously conducted clinical trials, and subsequently presents data arising from all phase II-III studies on chemotherapy of malignant pleural mesothelioma (MPM) published since the last relevant overview. While
Publikováno v:
Scandinavian Journal of Infectious Diseases. 25:269-269
dOSL,\. The major ohstack in the treatment of hydntid diseases in Turkey is the lack of patient compliance. Needless to say. the presence of only I00 mg tablet\ of mebendazole in Turkey and thc difficulty of swallowing 60 to 120 tablets at one time e